Ping Cheng

Head & Neck Department Of Radiation Oncology Of Sichuan Cancer Hospital & Institute
Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Development and validation of a self-management ability scale for patients with head and neck cancer undergoing radiotherapy and chemotherapy (SMA-HNC).

Development and validation of a self-management ability scale for patients with head and neck cancer undergoing radiotherapy and chemotherapy (SMA-HNC).

Journal: Scientific reports
Published: October 26, 2025

Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study.

Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study.

Journal: Carcinogenesis
Published: April 16, 2025

Ad-E6/7-HR vaccine improves the prophylactic and therapeutic efficacy in HPV-associated cancers.

Ad-E6/7-HR vaccine improves the prophylactic and therapeutic efficacy in HPV-associated cancers.

Journal: Clinical and translational medicine
Published: January 28, 2025

Effects of clay grains on the shear properties of unsaturated loess and microscopic mechanism.

Effects of clay grains on the shear properties of unsaturated loess and microscopic mechanism.

Journal: Scientific reports
Published: July 10, 2024

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.

Journal: Nature biomedical engineering
Published: February 11, 2024

A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.

A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.

Journal: MedComm
Published: November 23, 2023

CD44 and its implication in neoplastic diseases.

CD44 and its implication in neoplastic diseases.

Journal: MedComm
Published: August 01, 2023

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity.

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity.

Journal: Frontiers in immunology
Published: June 30, 2022

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.

Journal: Frontiers in oncology
Published: March 16, 2022

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy.

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy.

Journal: Frontiers in cellular neuroscience
Published: November 21, 2021

Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment.

Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment.

Journal: Human gene therapy
Published: August 18, 2021

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment.

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment.

Journal: Molecular therapy oncolytics
Published: April 02, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026